Company intelligence / Profile preview

ReNovo Biotech

College Station, Texas, United Statesrenovobiotech.com ↗

Ownership: Private
Development stage: Other

Overview

ReNovo Biotech is a medical technology company focused on the development and commercialization of advanced biologics for orthopedic and regenerative medicine. The company specializes in bone graft substitutes and regenerative technologies designed to enhance the natural healing process in complex surgical procedures. Their lead product offerings typically involve osteoinductive and osteoconductive materials used in spinal fusion and trauma surgery. ReNovo aims to improve patient outcomes by providing surgeons with high-quality, reliable alternatives to traditional autograft procedures.

Therapeutic areas: RheumatologyOther
Modalities: BiologicDeviceProteinAllograft
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on ReNovo Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReNovo Biotech.

Explore the full profile